Influence of Chlamydia trachomatis Sequence Variation on pgp3 Antigenicity

Area of Science:

• Microbiology
• Immunology
• Public Health

Background:

• Chlamydia trachomatis (Ct) causes significant health issues, including infertility, ectopic pregnancy, lymphogranuloma venereum (LGV), and trachoma.
• Disease-specific Ct genovars are linked to STI, LGV, and trachoma.
• Serological assays are crucial for tracking Ct exposure, but antigenicity variations due to genome differences remain unclear.

Purpose of the Study:

• To investigate the impact of Chlamydia trachomatis genome variation on the antigenicity of Pgp3 proteins.
• To determine if Pgp3 antigenicity differs significantly between strains causing STI, LGV, and trachoma.

Main Methods:

• Two-dimensional antigenicity profiling was employed.
• Murine sera specific to Pgp3 antigens from LGV, STI, and trachoma strains were used.
• Antigenicity was assessed using geometric distances between antigen-antibody interactions.

Main Results:

• Differential antigenicity of Pgp3 antigens was observed with antigen-specific murine sera.
• However, geometric distances were not significant (≤2 fold) when using human infection sera.
• This indicates conserved antigenicity of Pgp3 across different Ct pathotypes in human infections.

Conclusions:

• Pgp3 should be considered a single serotype for Chlamydia trachomatis serosurveillance.
• This finding simplifies serological monitoring for Ct infections.
• Supports the use of Pgp3-based assays for broad Ct exposure estimation.